Valeant Offering Needn't Meet Public Standards, SIFMA Says
The Securities Industry and Financial Markets Association urged a New Jersey federal court Wednesday to reject an attempt to hold Valeant Pharmaceuticals International Inc.'s private securities sale up to public sale...To view the full article, register now.
Already a subscriber? Click here to view full article